Table 1 Demographics and comorbidity factors of patients infected with NDM-producing vs. non-NDM Carbapenem-resistant Acinetobacter baumannii
Variable | NDM-A. baumannii (n = 54) | Non-NDM A. baumannii (n = 108) | p-value |
|---|---|---|---|
Female gender, N (%) | 22 (41) | 44 (41) | 1.0 |
Age (years), mean (S.D.) | 67.5 (19.6) | 66.4 (19.5) | 0.73 |
Hospital, N (%) SZMC RMC TASMC | 18 (33.3) 30 (55.6) 6 (11.1) | 36 (33.3) 60 (55.6) 12 (11.1) | 1.0 |
LTCF residency, N (%) | 10 (18.5) | 34 (31.5) | 0.08 |
Charlson Clinical Score (SD) | 3.81 (2.91) | 3.46 (2.76) | 0.45 |
Recent hospitalization (3 months), N (%) | 31 (57) | 64 (59) | 0.82 |
Recent surgery (3 months), N (%) | 12 (22.2) | 34 (31.5) | 0.21 |
Recent chemotherapy (1 month), N (%) | 4 (7.4) | 10 (9.3) | 0.69 |
Recent antimicrobial use (1 month), N (%) | 51 (94) | 89 (82) | 0.035 |
Recent use of urinary catheter (1 week), N (%) | 33 (61) | 61 (56) | 0.57 |
Recent use of CVC (1 month), N (%) | 21 (39) | 37 (34) | 0.56 |
Recent mechanical ventilation (1 week), N (%) | 21 (39) | 48 (44.4) | 0.5 |
First isolation from surveillance, N (%) | 41 (76) | 78 (72) | 0.61 |